Thursday, December 12, 2013

Rod Peterson Cured Cancer Using Dr. Simoncini's Baking Soda Method

Published on Jul 20, 2013

Cancer is cured with Baking Soda (sodium bicarbonate)

Rod Peterson was diagnosed with end stage cancer and was advised to see a psychologist, since the doctor basically told him he was going to die. Instead, Rod turned to Dr Simoncini's Baking Soda treatment.

Cancer is cured with Baking Soda (sodium bicarbonate)

Mirror of a very helpful video showing cancer is not an incurable condition, but is actually a fungus that is cured with sodium bicarbonate (Baking Soda).

JudeoChristian Dr Simoncini shows sodium bicarbonate cures colon cancer in 5 days

1- Sodium bicarbonate, a natural way to treat the cancer

The reason this cancer cure is being suppressed by the American medical Association is because a cure for cancer would shut down a "cancer treatment" industry that earns billions of dollars per year. It's all dollars and cents (not sense) in capitalist extremist America. The capitalist media was sold to the highest billionaires, so the "cancer treatment" industry tells the US media to suppress these facts. They simply do not want a cancer cure or they will lose billions.

Dr Simoncini says cancer is a fungus, all fungus dies in a high pH environment, and sodium bicarbonate raises the pH in the body.

I would advise, if sodium bicarbonate cures cancer, then the people working in America's "cancer treatment" industry need to find another job. In socialist Sweden the govt would find all these people good jobs with similar salaries. In capitalist America these people losing their jobs can wind up homeless with no health care. Hence the rabid resistance to anyone coming up with cures for these ailments.

It appears the capitalist American corporations are using COINTELPRO on activists whose work, if successful, could cost those large corporations billions of dollars in lost revenue. Capitalist medical corporations don't want cures because it deprives them of money

For protection visit The Protection Group

No comments: